FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Heyu Biological Technology Corporation Stock AnalysisComprehensive stock analysis for Heyu Biological Technology Corporation (HYBT) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHYBT
HYBT
Heyu Biological Technology Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HYBT
Home🔹Stocks🔹Heyu Biological Technology Corporation

Heyu Biological Technology Corporation

HYBT•OTC

Heyu Biological Technology Corporation

HYBT•OTC
Market cap
$361.36M
Sentiment

Your view on HYBT

Mkt Cap
$361.36M
Sentiment
Your view
HYBT
Heyu Biological Technology Corporation
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
HYBT
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Heyu Biological Technology Corporation

Industry
Medical - Devices
Sector
Healthcare
CEO
Ban Siong Ang
Headquarters
Baotuo Building, Xiamen, CN
Industry
Medical - Devices
Sector
Healthcare
CEO
Ban Siong Ang
Headquarters
Baotuo Building, Xiamen, CN
Description

Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News